4th Quarter - Report

PODESTA GROUP, INC. for GENENTECH

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act H. R. 4911, Human Growth Hormone Restriction Act of 2007 S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 877, Controlling Abuse of Prescription Drugs Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
COURTNEY HAGEN —
ANDREW KAUDERS Sr. Adv. Sen. Menendez; ED, House Dem Caucus
ELIZABETH ANN MORRA —
ANTHONY PODESTA —
NICOLE C YOUNG New —

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; Patent & Trademark Office (PTO)

Bills named: H.R. 1956 (110th), S. 1505 (110th), S. 1695 (110th), S. 623 (110th), H.R. 5839 (110th), H.R. 1038 (110th), S. 2029 (110th), S. 596 (110th), H.R. 4911 (110th), H.R. 5629 (110th), S. 877 (110th)

Medicare/Medicaid MMM

H. R. 5480, Medicare Funding Warning Response Act of 2008 H.R. 1424, Emergency Economic Stabilization Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 Comparative Effectiveness

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
ANDREW KAUDERS Sr. Adv. Sen. Menendez; ED, House Demo Caucus
ANTHONY PODESTA —
NICOLE C YOUNG New —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE; Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 5480 (110th), S. 2662 (110th), S. 2029 (110th), H.R. 1424 (110th)

Medical/Disease Research/Clinical Labs MED

LHHS Appropriations (CMS and comparative effectiveness related matters)

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
NICOLE C YOUNG New —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007, entire bill H. R. 1908, Patent Reform Act of 2007, entire bill S. 3600, Patent Reform Act of 2008, entire bill

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
COURTNEY HAGEN —
CLAUDIA JAMES —
ANTHONY PODESTA —
NICOLE C YOUNG New —

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Executive Office of the President (EOP); SENATE

Bills named: S. 1145 (110th), S. 3600 (110th), H.R. 1908 (110th)

Budget/Appropriations BUD

House Concurrent Resolution 312 FY09 Budget Resolution Senate Concurrent Resolution 70 FY09 Budget Resolution Comparative Effectiveness

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
ANTHONY PODESTA —
NICOLE C YOUNG New —

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.